AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 65 filers reported holding AVROBIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000 | +50.0% | 1,979 | -14.9% | 0.00% | – |
Q2 2023 | $2,000 | 0.0% | 2,325 | +24.7% | 0.00% | – |
Q1 2023 | $2,000 | +100.0% | 1,865 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | 0.0% | 1,865 | -17.4% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 2,257 | +15.4% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 1,955 | -53.4% | 0.00% | – |
Q1 2022 | $5,000 | -86.1% | 4,192 | -55.6% | 0.00% | – |
Q4 2021 | $36,000 | +12.5% | 9,440 | +61.6% | 0.00% | – |
Q3 2021 | $32,000 | -99.6% | 5,843 | -99.3% | 0.00% | -100.0% |
Q2 2021 | $7,455,000 | +13454.5% | 838,548 | +19519.7% | 0.00% | – |
Q1 2021 | $55,000 | +96.4% | 4,274 | +112.4% | 0.00% | – |
Q4 2020 | $28,000 | +16.7% | 2,012 | +7.9% | 0.00% | – |
Q3 2020 | $24,000 | -29.4% | 1,865 | -2.6% | 0.00% | – |
Q2 2020 | $34,000 | +9.7% | 1,914 | -3.3% | 0.00% | – |
Q1 2020 | $31,000 | +10.7% | 1,979 | +43.3% | 0.00% | – |
Q4 2019 | $28,000 | +2700.0% | 1,381 | +2024.6% | 0.00% | – |
Q4 2018 | $1,000 | -83.3% | 65 | -48.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
Western Standard LLC | 310,361 | $477,956 | 0.43% |
Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |